Merial, a world-leading animal health company, has gained full-licensure from the U.S. Department of Agriculture for ONCEPT Canine Melanoma Vaccine, DNA. ONCEPT is a breakthrough vaccine indicated for aiding in extending survival of dogs with stage II or stage III oral canine melanoma, a common yet deadly form of cancer in dogs.
Source: DogMagazine.net – the K9 Magazine blog
Breakthrough Vaccine To Help Dogs Suffering From Oral Canine Melanoma
Related content: